Impact of Metabolic Dysfunction-Associated Steatotic Liver Disease and Associated Comorbidities on Cognitive and Health-Related Quality-of-Life Outcomes in a Mixed Metabolic Dysfunction-Associated Steatotic Liver Disease-Type 2 Diabetes Mellitus Coho
Our findings highlight the relationship between MASLD severity and impairment in cognitive function and HRQoL, underscoring its multifactorial nature. Specifically, severe hepatic steatosis may be a risk factor of cognitive decline, whereas significant or high LS seems to greatly affect HRQoL.
Authors
- Gian Paolo Caviglia (ORCID: https://orcid.org/0000-0002-0529-9481)
- Chiara Rosso (ORCID: https://orcid.org/0000-0001-6518-7089)
- Eleonora Dileo (ORCID: https://orcid.org/0009-0006-4970-7762)
- Nuria Pérez-Díaz-del-Campo (ORCID: https://orcid.org/0000-0003-0479-8825)
- Elisabetta Bugianesi (ORCID: https://orcid.org/0000-0002-0502-4381)
- Angelo Armandi (ORCID: https://orcid.org/0000-0002-7245-4445)
- Gabriele Castelnuovo (ORCID: https://orcid.org/0000-0002-9985-1440)
- Guglielmo Beccuti (ORCID: https://orcid.org/0000-0003-3163-2361)
- Zobair M. Younossi (ORCID: https://orcid.org/0000-0001-9313-577X)
- Marta Guariglia (ORCID: https://orcid.org/0000-0003-1389-7278)
- Francesca Saba (ORCID: https://orcid.org/0000-0001-5133-2994)
- Giorgio Maria Saracco (ORCID: https://orcid.org/0000-0001-5310-4143)
- Arianna Ferro (ORCID: https://orcid.org/0000-0002-1450-7035)
Institutions
- Fondazione Ricerca Molinette (IT)
- Department of Medical Sciences (BY)
- University of Turin (IT)
Publication Details
- Journal
- The American Journal of Gastroenterology
- Published
- 2025-06-11
- DOI
- https://doi.org/10.14309/ajg.0000000000003594
- Citations
- 2
- Primary Topic
- Cardiovascular Disease and Adiposity
- Type
- article
- Field-Weighted Citation Impact
- 2.78